Connect with us

Press Release

ZUBR Has Become a Leader in the NMN Industry at Home and Abroad

Published

on

As the global economy continues to grow and life expectancy continues to rise, the proportion of elderly people aged 65 years and above continues to increase, and global attention to health issues continues to increase. The life expectancy issue has become one of the ultimate problems that mankind has continued to strive to solve in the history of mankind. In recent years, global academic research has shown that NMN has become a consensus anti-aging health care product.

The full name of NMN is β-nicotinamide mononucleotide, which is the precursor for the synthesis of NAD+ (coenzyme I) in the human body. Since NAD+ is a coenzyme for hundreds of important metabolic enzymes in cells, it also participates in many important cellular processes as a signal molecule. It is closely related to energy metabolism, glycolysis, DNA replication and other activities. NMN can increase the level of NAD+ in the body and is considered a health product with anti-aging functions. Compared with other products, NMN products enhance NAD+ and have the advantages of non-toxic side effects and high conversion efficiency. At present, the academic community has confirmed that NMN has the following 10 major functions: support NAD+ production (NAD+ is an indicator of aging in the body), activate longevity protein/gene SIRTUINS, repair DNA damage, support energy production, enhance metabolism, help enhance physical endurance and vitality, and helps improve blood vessel and muscle physiology, helps weight management, helps brain and heart health, helps improve insulin sensitivity, etc.

As one of the world-class academic achievements, Professor David Sinclair of Harvard University used NMN raw materials and published the research results of NAD+ reversing blood aging in the top academic journal “Cell”. From the age of 30, the NAD+ content in the body decreases significantly. At the age of 60, the level of NAD+ is less than a quarter of that of young people. This means that after 60 years of age, there are many biochemical and metabolic reactions in the human body that cannot be efficiently carried out. Therefore, the older the age, the more health problems become.

How to effectively supplement NMN? According to the FDA’s principle of equivalence, a 70Kg adult should be supplemented with 300mg of NMN per day, and an adult with the same amount of NMN needs to eat 32~128kg of edamame, or 54~240kg of broccoli. It is less efficient to supplement NMN through food sources in nature, and NMN products can achieve this effect faster. After taking NMN in the human body, the study found that the NAD+ content in the body increased significantly after 5 minutes, and the supplement effect was significantly improved.

ZUBR® from the United States is a high-tech company focusing on anti-aging research and product development for a long time. Headquartered in New York, USA, ZUBR® brand Slogan is Anti-aging From Young, advocating the life concept of “anti-aging while young”. ZUBR® introduces anti-aging explosives such as NMN to the United States, Europe and Asia, bringing a healthy lifestyle of “anti-aging while young” to hundreds of millions of middle-class people around the world. ZUBR® has the core production qualifications of health care products such as FDA, NSF GMP, and has mastered core production technology. According to the laboratory test results of US Pharmatech, ZUBR® NMN developed by biological enzymatic method has the characteristics of high purity, high absorption and conversion rate, and the effective purity is higher than that of products in the same industry.

At present, ZUBR® has many flagship products such as NMN Pro and NMN Honor, and the product line fully meets the needs of different users. Among them, the NMN Pro product comes in small bottles, which is currently the only product on the market with a weekly pack (14 capsules) as a unit, which is especially suitable for urban white-collar people to carry during their daily commuting. Each bottle of NMN Pro contains 14 high-concentration NMN capsules, which can be used for a week, and each time it is taken, it can supplement 340mg NMN and 100mg resveratrol. NMN Honor provides a more powerful dose of NMN, suitable for reuse in the morning at home. It can supplement 480mg of NMN and 100mg of resveratrol each time. Each bottle provides 90 capsules for 45 days of continuous use.

Overseas, ZUBR® has won praise from a large number of users with its excellent product strength. Bryan Gunn, an automotive industry designer from Ohio, USA, said, “After taking it, I feel my body is full of vitality, my sleep quality has unexpectedly improved, and I feel my mind is clearer”. Dean Norris, a fund manager from Wall Street in New York, United States, said, “Day 1: 2 capsules in the morning, the body has a significant reaction in the afternoon, and fatigue is reduced; Day 2: 2 capsules in the morning, I feel more clear-headed; 4, 5 days: One hour after each consumption, you can feel your mind becomes clearer and no longer tired; 6th and 7th days: More energy and weight loss than before.” Peter Gould, a Java development engineer from California, said, “Since taking it, I have been very stable and sustained vitality throughout the day. This is an experience I haven’t had before trying other health foods.”

ZUBR® officially entered the Asian market in 2019, using word of mouth as the lifeline of the company’s survival and development. At the same time, in combination with the actual needs of the Asian market, the product price is reduced to a level that can be purchased by the general public while meeting the effective dose. We have reason to believe that ZUBR® will soon become the leading brand in the field of anti-aging health food.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Alex Cecola Highlights the Growing Importance of Due Diligence Before Making Investment Decisions

Published

on

Chicago, Illinois, September 6th, 2026, ZEX PR WIRE, Alex Cecola, Founder of Vincere Portfolios, a Chicago-based trading technology company, is speaking out on a topic he believes deserves more attention from everyday investors: the discipline of due diligence. As markets continue to attract new participants drawn in by social media hype and unverified claims of success, Alex Cecola says the gap between marketing and reality has never been more important to close.

Vincere Portfolios was built on the idea that individual traders deserve access to the same standards of transparency and structure that institutions have long relied on. That mission now extends into a broader conversation about how investors, at every level, should evaluate opportunities before committing capital.

For Alex Cecola, the conversation is not abstract. He has spent years studying how both discretionary and algorithmic traders make decisions, and he has seen firsthand how quickly good intentions can be undone by a lack of preparation. That experience continues to shape how he speaks publicly about investor behavior today.

A Market That Rewards Preparation

Financial markets have always rewarded preparation over impulse, but Alex Cecola notes that the tools available to retail investors today make it easier than ever to skip that preparation entirely. Automated platforms, rapid-fire content, and one-click investing have lowered the barrier to entry. They have not, however, lowered the risk.

According to Cecola, this combination creates a dangerous shortcut. Investors can move capital in seconds, often based on a headline, a chart screenshot, or a stranger’s claim of returns. Few of those decisions involve any meaningful verification.

He points out that speed and convenience are not inherently negative. Technology has made markets more accessible than ever before, and that accessibility can benefit investors who use it responsibly. The concern, he says, arises when convenience replaces judgment rather than supporting it.

“The ease of access is not the same as the quality of the decision,” Cecola said. “Just because you can invest quickly does not mean you should skip the steps that protect your capital.”

The Case for Verifiable Performance

A central theme in Cecola’s message is the importance of verifiable performance. Too often, he explains, trading results are presented without context: no audited records, no consistent timeframes, and no clear methodology behind the numbers.

Alex Cecola argues that performance claims should be treated as a starting point for questions, not a finish line. Investors should ask how results were generated, over what period, under what market conditions, and whether the same process would hold up during a downturn.

Vincere Portfolios has structured much of its own approach around this principle, emphasizing systematic processes that can be reviewed and understood rather than results presented in isolation.

Transparency as a Standard, Not a Bonus

Cecola is direct about where he believes the industry falls short. Transparency, he says, is too often treated as an optional feature rather than a baseline expectation.

“When transparency is missing, that absence is information in itself,” Cecola said. “Investors should pay attention to what isn’t being shown, not just what is being promoted.”

This philosophy shapes how Vincere Portfolios approaches its own trading technology. The company was built around the belief that traders should understand the logic behind a strategy, not simply trust that it works. Automation, in this view, should support clarity rather than obscure it.

Independent Research Over Assumptions

Alex Cecola also points to the role of independent research in protecting investors from decisions driven by convenience or trend. Relying solely on a platform’s own marketing materials, he explains, creates an incomplete picture.

He encourages investors to look beyond a single source before allocating capital. That includes reviewing third-party data where available, understanding a strategy’s historical drawdowns, and evaluating whether risk management practices are clearly defined.

Cecola frequently returns to a simple distinction in his own approach: separating emotion-driven decisions from process-driven ones. He believes the same standard should apply to due diligence itself.

“Research should challenge your assumptions, not just confirm them,” he said. “If everything you’re reading agrees with what you already want to believe, that’s a signal to look further.”

Vincere Portfolios’ Approach to Disciplined Investing

Since founding Vincere Portfolios, Alex Cecola has focused on building systematic trading tools designed around consistency, efficiency, and education. The company’s goal has been to give individual traders access to institutional-grade infrastructure without requiring them to abandon careful evaluation along the way.

Cecola’s background studying both discretionary and algorithmic trading strategies informs this approach. He has spent years examining risk management frameworks and performance evaluation methods, experience that shaped his conviction that long-term results come from process rather than prediction.

Vincere Portfolios continues to emphasize automation paired with clear, understandable methodology. The company’s broader aim is to help traders understand not just the potential upside of a strategy, but the risks embedded within it.

Looking Ahead

As markets evolve and new investment products continue to emerge, Alex Cecola expects due diligence to become even more central to responsible investing. He points to the increasing availability of trading technology as both an opportunity and a responsibility: tools are more powerful, but the need for scrutiny grows alongside them.

Cecola plans to continue contributing to public conversations on algorithmic trading, market technology, and investor education. Through Vincere Portfolios, he intends to keep building tools that reward preparation and informed decision-making over speed alone.

“Markets will always offer shortcuts,” Cecola said. “The investors who do well over time are usually the ones who choose not to take them.”

About Vincere Portfolios

Vincere Portfolios is a Chicago-based trading technology company founded by Alex Cecola. The company focuses on making institutional-grade systematic trading tools more accessible to individual investors, with an emphasis on automation, transparency, and education. Vincere Portfolios is built around the belief that disciplined, data-based processes, rather than emotion-driven decision making, lead to stronger long-term outcomes in the markets. Under Cecola’s leadership, the company continues to develop tools and resources designed to help traders better understand both the opportunities and risks present in today’s financial markets.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Hilltop Painting Brings Trusted Interior and Exterior Painting to Whatcom and Skagit County Homes

Published

on

Family-owned Hilltop Painting serves Bellingham and all of Whatcom and Skagit County with interior painting, exterior painting, cabinet refinishing, drywall repair, and commercial painting. The company holds a 4.9 rating across 185 customer reviews and handles every job from the free written estimate to the final walkthrough. Learn more at hilltoppainting.com or (360) 310-8391.

Bellingham, Washington, United States, 5th Sep 2026 – BELLINGHAM, Washington – September 4, 2026 – Hilltop Painting, a family-owned painting company based in Bellingham, provides interior painting, exterior painting, cabinet refinishing, drywall and sheetrock repair, and commercial painting for homeowners and businesses across Whatcom County and Skagit County, Washington.

The company works in Bellingham, Ferndale, Lynden, Blaine, Birch Bay, Everson, Nooksack, Sumas, Custer, and Sudden Valley, and across Skagit County in Anacortes, Burlington, Mount Vernon, and Sedro-Woolley. Crews handle everything from single rooms to full exterior repaints, kitchen cabinet refinishing, new construction, and multi-building commercial projects such as offices, warehouses, and homeowner associations.

Northwest Washington weather is hard on paint. Salt air off the coast, valley fog, and more than 35 inches of rain a year mean preparation matters more than the final coat. Hilltop Painting pressure washes, scrapes, primes, and repairs rotten wood before any paint goes on, and uses Sherwin-Williams products matched to each surface. Every project ends with a final walkthrough, and nothing gets called done until it looks right.

“We treat every house like a neighbor’s house, because around here it usually is one,” said Daniel Kolbert, owner of Hilltop Painting. “Do the prep right, use good materials, show up when you said you would, and stand behind the work. That is the whole playbook.”

Hilltop Painting holds a 4.9 out of 5 rating across 185 customer reviews on Google, Thumbtack, Angi, Yelp, and Facebook. The company is licensed and insured in Washington State and is an EPA Lead-Safe Certified firm for work on homes built before 1978, which covers much of Bellingham’s Columbia, Sunnyland, and York neighborhoods. Beyond painting, the team offers stucco painting, historic exterior repaints, carpentry and wood replacement, pressure washing, and color consultations with real brushed-out samples.

Free written estimates are available year-round. Homeowners can see completed local projects, real Sherwin-Williams colors, and verified customer reviews at hilltoppainting.com.

About Hilltop Painting

Hilltop Painting is a family-owned, full-service painting company in Bellingham, Washington, serving all of Whatcom and Skagit County. Services include interior house painting, exterior house painting, cabinet painting and refinishing, drywall and sheetrock repair, commercial painting, carpentry, stucco painting, historic exterior painting, and lead paint removal. Call or text (360) 310-8391 or visit hilltoppainting.com for a free written estimate.

Media Contact

Organization: Hilltop Painting

Contact Person: Daniel

Website: https://hilltoppainting.com/

Email:
office@hilltoppainting.com

Contact Number: +13603108391

Address:2219 Rimland Dr, Bellingham, WA 98226

City: Bellingham

State: Washington

Country:United States

Release id:48859

The post Hilltop Painting Brings Trusted Interior and Exterior Painting to Whatcom and Skagit County Homes appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

OpAIda Opens Office at Plug and Play, Unveiling AI Strategy Across the Life Sciences Value Chain

Published

on

Sunnyvale, CA, United States, 5th Sep 2026 – opAIda, an enterprise artificial intelligence company focused on transforming complex, knowledge-intensive workflows, today celebrated the grand opening of its Silicon Valley office at Plug and Play Tech Center in Sunnyvale, California.

The opening marked more than a geographic expansion for opAIda. It represented an strategic step as the company sharpened its focus on Life Sciences and advanced its vision for an AI platform designed to support key workflows across the industry’s value chain.

From Regulatory AI to the Life Sciences Value Chain

Drug development generates enormous volumes of scientific, clinical, quality, regulatory and operational information. Yet many of the workflows connecting that information remain involve manual processes, multiple systems and specialized human expertise. OpAIda sees an opportunity for enterprise AI to change that.

The company is initially concentrating on one of the most document-intensive and consequential areas of the pharmaceutical industry: regulatory and FDA report writing.

Rather than treating report writing simply as a generative AI task, opAIda is developing AI-enabled workflows designed to help life sciences organizations organize source information, retrieve supporting evidence, generate structured content, conduct quality reviews and maintain traceability throughout the reporting process.

The company’s initial target customers include pharmaceutical companies, biotechnology companies and contract research organizations (CROs).

From this regulatory entry point, opAIda plans to progressively extend its capabilities across the broader life sciences value chain: Research > Discovery & Design > Pathology & Biomarkers > Clinical Development > Regulatory > Manufacturing & Supply Chain > Commercial

The goal is to create an increasingly connected intelligence layer that helps scientific and business teams work with complex enterprise knowledge throughout the drug lifecycle.

“At opAIda, we are not building AI simply because AI is exciting. We want to solve real problems where complexity, knowledge and human expertise matter,” said Zhenni Jackson, CEO and co-founder of opAIda. “Life sciences is exactly that kind of industry. Developing a medicine can take years, involve thousands of decisions and generate enormous amounts of scientific and regulatory documentation. We believe AI can help people connect that knowledge, reduce repetitive work and support these workflows with AI-enabled capabilities.”

Zhenni Jackson, CEO and co-founder of opAIda, speaks at opAIda’s Silicon Valley office grand opening.

Zhenni Jackson, CEO and co-founder of opAIda, speaks at opAIda’s Silicon Valley office grand opening.

According to Jackson, the company’s strategy is very focused: enter through regulatory, then expand across the life sciences value chain. FDA report writing gives the company a practical starting point where there is a clear operational need and the value of automation can be evaluated. From there, opAIda’s ambition is much bigger—to help intelligence flow from research and drug development all the way to manufacturing and commercialization.”

“AI in Life Sciences must be built around trust, context and accountability,” said Dr. Yingchao Zhang, Dr. YZ, Co-Founder and Chief AI Officer of opAIda. “Our goal is to develop systems that can work with complex scientific and regulatory knowledge while preserving traceability and keeping experts in control. By combining AI technologies  with domain-specific workflows, we can help organizations improve workflow efficiency while maintaining the rigor required to make decisions that affect patients.”

A new chapter as opAIda sets a presence at Plug and Play

Plug and Play is one of the world’s largest innovation platforms, with a global network spanning more than 550 corporate partners, 60-plus cities and 25-plus industry verticals. The platform manages more than $1 billion in assets under management and has supported more than 100,000 startups, including more than 2,500 portfolio companies and over 30 unicorns. Its ecosystem includes more than 1,000 mentors and more than 100 accelerator and innovation programs worldwide.

At opAIda’s grand opening, Dr. Yingchao Zhang, Chief AI Officer of opAIda, introduced Rouzbeh Borhani, Head of Semiconductors at Plug and Play, who welcomed opAIda to Silicon Valley on behalf of Plug and Play.

“Plug and Play is proud to welcome opAIda to our Silicon Valley community,” said Rouzbeh Borhani, Head of Semiconductors at Plug and Play. “The company’s focus on applying enterprise AI to complex Life Sciences workflows reflects the kind of meaningful, practical innovation we seek to support. We look forward to helping opAIda leverage Plug and Play’s global network of corporations, investors, startups and technology partners as it grows its presence, develops strategic relationships and expands across the Life Sciences value chain.”

Building Enterprise AI Around Knowledge, Not Just Prompts

opAIda’s approach centers on AI systems capable of working with complex enterprise information rather than relying solely on general-purpose chatbot interactions.

Its technology is being developed to support document-intensive workflows involving knowledge retrieval, structured generation, review, quality control and enterprise data integration.

This approach is particularly relevant in life sciences, where AI-generated output must be grounded in source information and operate within highly controlled business and regulatory environments.

The company believes the next phase of enterprise AI will move toward AI-enabled workflows that understand organizational knowledge and assist humans throughout complete business processes.

Against this backdrop, the opening represented both a celebration and a declaration of its next chapter.

Plug&Play lobby where OpAIda now has a presence.

“Silicon Valley has always represented the courage to imagine what does not exist yet,” Jackson said. “For opAIda, this office is small in square footage, but reflects the company’s broader ambitions.”

About opAIda 

opAIda — AI for Real-World Applications is an enterprise artificial intelligence company developing AI solutions for complex, knowledge-intensive workflows.

The company is sharpening its focus on the Life Sciences value chain, beginning with regulatory and FDA report writing for pharmaceutical, biotechnology and CRO organizations and building toward broader applications across research, drug discovery and development, clinical operations, regulatory affairs, manufacturing and supply chain, and commercialization.

opAIda combines enterprise knowledge, AI models and workflow automation to help teams organize information into usable insights while keeping human expertise at the center of critical decisions.

With its new Silicon Valley presence at Plug and Play Tech Center, opAIda is building toward a larger vision: AI for Real-World Impact. From Regulatory Intelligence to the Life Sciences Value Chain.

Media Contact

Organization: opAIda

Contact Person: Zhenni Jackson

Website: https://opaida.ai/

Email:
zhenni.jackson@opaida.ai

City: Sunnyvale

State: CA

Country:United States

Release id:48726

The post OpAIda Opens Office at Plug and Play, Unveiling AI Strategy Across the Life Sciences Value Chain appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST